This action leads to increased acetylcholinesterase (AChE) activity and reduces cholinergic neurotransmission, resulting in cognitive deficits that resemble the pathological features of AD (Chen et al., 2022; Zhang J. et al., 2024). This evidence concerns the gene ACHE and Alzheimer disease.